Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek C Angus

Showing results (561-570 of 582) with videos related to

Pageof 59
Sort By:
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
Critical Care Medicine|March 23, 2026
Executive Summary: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzani, et al.
Critical Care Medicine|March 23, 2026
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzani, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
Intensive Care Medicine|May 5, 2026
Publisher Correction: Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzani, et al.
Intensive Care Medicine|March 23, 2026
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzanic, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax|May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
The New England Journal of Medicine|October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19, Thomas E Hills, Elizabeth Lorenzi, et al.
Pageof 59

Showing results (561-570 of 582) with videos related to

Sort By:
Pageof 59
Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
Critical Care Medicine|March 23, 2026
Executive Summary: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzani, et al.
Critical Care Medicine|March 23, 2026
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzani, et al.
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
Intensive Care Medicine|May 5, 2026
Publisher Correction: Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzani, et al.
Intensive Care Medicine|March 23, 2026
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026Hallie C Prescott, Massimo Antonelli, Waleed Alhazzanic, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax|May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
The New England Journal of Medicine|October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19, Thomas E Hills, Elizabeth Lorenzi, et al.
Pageof 59